Bionano Genomics, Inc. 10-K filing
Filed 2026-03-23 · Report date 2025-12-31 · 2025 FY
Filing metadata
- Accession number
- 0001411690-26-000007
- Form type
- 10-K
- CIK
- 0001411690
- Primary document
- https://www.sec.gov/Archives/edgar/data/1411690/000141169026000007/bngo-20251231.htm
Extracted primary information
This filing includes deterministic financial metrics extracted from public filing data for Bionano Genomics, Inc..
Reported financial metrics
| Metric | Current | Prior | Change |
|---|---|---|---|
| Revenue | $28.5M | - | - |
| Cost Of Revenue | $15.3M | - | - |
| Operating Income | $-33.3M | - | - |
| Net Income | $-26.4M | - | - |
| Eps Basic | -4.85 | - | - |
| Eps Diluted | -4.85 | - | - |
| Cash And Equivalents | $3.0M | - | - |
| Total Assets | $73.6M | - | - |
| Total Liabilities | $29.2M | - | - |
| Shareholders Equity | $44.4M | - | - |
| Operating Cash Flow | $-16.3M | - | - |